Antonio Valero

Pneumology and Allergy Department Allergist

valero@clinic.cat 0000-0001-6266-2585

Featured publications

Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis

Authors:
Mullol J; Izquierdo I; Okubo K; Canonica GW; Bousquet J;

Valero A .

Reference: Clinical And Translational Allergy 2019.
Efficacy and safety of reslizumab in severe asthma patients with inadequate response to omalizumab: a multicentre, open-label, pilot study

Authors:
Pérez de Llano LA; Cosío BG; Domingo C; Urrutia I; Bobolea I;

(...)

Quirce S; Barranco P; Marina Malanda N; Andrés LP; Alvarez-Gutiérrez FJ .

Reference: Journal Of Allergy And Clinical Immunology-In Practice 2019.
Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications

Authors:
Muñoz-Cano RM; Casas-Saucedo R; Valero Santiago A; Bobolea I; Ribó P;

Mullol J .

Reference: Journal Of Clinical Medicine 2019.
Asthma patient satisfaction with different dry powder inhalers

Authors:
Valero A; Ribó P; Maíz L; Barbero E; Calle M;

Campo C; Rytilä P; Giner J; Plaza V .

Reference: Expert Review Of Ophthalmology 2019.
Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)

Authors:
Jauregui I; Gimenez-Arnau A; Bartra J; Labrador-Horrillo M; de Frutos JO;

(...)

Sastre J; Velasco M; Ferrer M; Ballesteros C; Valero A .

Reference: Health And Quality Of Life Outcomes 2019.
Re-evolution of asthma management: dilemmas and new paradigms

Authors:
Valero A; Olaguibel J; Delgado J; Plaza V; Álvarez F;

Molina J; Mascarós E; Quirce S.

Reference: Journal Of Investigational Allergology And Clinical Immunology 2019.
Severity of allergic rhinitis impacts sleep and anxiety: results from a large Spanish cohort

Authors:
Muñoz-Cano R; Ribó P; Araujo G; Giralt E; Sanchez-Lopez J;

Valero A .

Reference: Clinical And Translational Allergy 2018.
Safety and Quality Recommendations in Allergy Medicine (Spanish acronym, RESCAL)

Authors:
Vidal, C.; Antolin, D.; Reano, M.; Valero, A.; Sastre, J.;;

Reference: Journal Of Investigational Allergology And Clinical Immunology 2018.
Impact of Rhinitis on Work Productivity: A Systematic Review

Authors:
Vandenplas O; Vinnikov D; Blanc PD; Agache I; Bachert C;

(...)

Sastre J; Tian L; Valero AL; Zhang X; Bousquet J.

Reference: Journal Of Allergy And Clinical Immunology-In Practice 2018.
The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study.

Authors:
Bousquet J; Arnavielhe S; Bedbrook A; Fonseca J; Morais Almeida M;

(...)

Melén E; Wickman M; van Eerd M; De Vries G; MASK study group.

Reference: Allergy 2018.

Featured Projects

Estudio de los mecanismos por los cuales el Omalizumab es capaz de mejorar el asma persistente asociada a la Enfermedad Respiratoria Exacerbada por AINES (EREA)

Principal investigator: Irina Bobolea

Funder: SEPAR

Code: SEPAR'18

Duration: 01/01/2019 - 31/12/2021
Study of the antiinflammatory mechanisms of action of MP29-02, compared to fluticasone propionate and azelastine alone, in healthy and inflamed human ansal mucosa: regulation on anti- and pro-inflammatory genes and GR.

Principal investigator: Joaquim Mullol I Miret

Funder: MEDA Pharma

Code: DYMECOS II

Duration: 01/01/2016 - 31/12/2019
Efecto clínico e inflamatorio nasal tras la aplicación frl factor de agregación plaquetaria (PAF).

Principal investigator: Valero AL

Code: PI0901202.

Duration: 01/01/2010 - 30/12/2012
Inhibición del efecto de la administración nasal del Factor de Activación Plaquetaria (PAF) tras la administración de Rupatadina (NARUPAF).

Principal investigator: Joaquim Mullol Miret, Valero AL

Code: DC/03/RUP/I/08.

Duration: 01/09/2008 - 31/03/2010
Estudio de evaluación de la respuesta nasal tras la aplicación intranasal de Rupatadina en sujetos con rinitis alérgica persistente (ATORUP).

Principal investigator: Joaquim Mullol Miret, Valero AL

Code: DC/05/RUP/I/08.

Duration: 01/07/2008 - 31/05/2009

Antonio Valero

Featured publications

Featured Projects

Estudio de los mecanismos por los cuales el Omalizumab es capaz de mejorar el asma persistente asociada a la Enfermedad Respiratoria Exacerbada por AINES (EREA)

Study of the antiinflammatory mechanisms of action of MP29-02, compared to fluticasone propionate and azelastine alone, in healthy and inflamed human ansal mucosa: regulation on anti- and pro-inflammatory genes and GR.

Efecto clínico e inflamatorio nasal tras la aplicación frl factor de agregación plaquetaria (PAF).

Inhibición del efecto de la administración nasal del Factor de Activación Plaquetaria (PAF) tras la administración de Rupatadina (NARUPAF).

Estudio de evaluación de la respuesta nasal tras la aplicación intranasal de Rupatadina en sujetos con rinitis alérgica persistente (ATORUP).

Subscribe to the Newsletter of Clínic